Peter Kolkhof
0000-0003-3425-7528
9 papers found
Refreshing results…
Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney protective mechanism of mineralocorticoid receptor antagonists
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems
Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease
Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
Missing publications? Search for publications with a matching author name.